Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
COVID Central
Rewinds
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Search
Thursday, March 4, 2021
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Cabozantinib improves progression-free survival in patients with metastatic papillary renal cell…
Type 1 spinal muscular atrophy improved with risdiplam
Tocilizumab reduced COVID-19 disease related adverse health outcomes
Everolimus treatment effective for improving renal function in lung transplant patients
Classics™
COVID Central
Rewinds
2 Minute Medicine Rewind March 1, 2021
2 Minute Medicine Rewind February 22, 2021
2 Minute Medicine Rewind February 8, 2021
2 Minute Medicine Rewind Jan 25, 2021
2 Minute Medicine Rewind January 25, 2021
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Tag: cancer
#VisualAbstract CASTOR trial follow-up: Health-related quality of life was maintained in patients treated with daratumumab, bortezomib, and dexamethasone over time for relapsed or refractory multiple myeloma
Kathleen Lau
-
March 4, 2021
0
Read more
#VisualAbstract Asciminib is shown to be safe and efficacious in clinical practice for treating patients with chronic myeloid leukemia
Kathleen Lau
-
February 26, 2021
0
Read more
#VisualAbstract Panobinostat, lenalidomide, bortezomib, and dexamethasone was well-tolerated and showed potential in treating relapsed/refractory multiple myeloma
Kathleen Lau
-
February 25, 2021
0
Read more
#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes
Kathleen Lau
-
February 19, 2021
0
Read more
#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma
Kathleen Lau
-
February 18, 2021
0
Read more
#VisualAbstract Low-PV study: Adding ropeginterferon alfa-2b to phlebotomy and aspirin shows improvement in response rates for treatment of polycythaemia vera in low-risk patients
Kathleen Lau
-
February 12, 2021
0
Read more
#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Kathleen Lau
-
February 11, 2021
0
Read more
Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma
Kathleen Lau
-
February 5, 2021
0
Read more
#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia
Kathleen Lau
-
February 4, 2021
0
Read more
#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis
Kathleen Lau
-
January 29, 2021
0
Read more
1
2
3
...
10
Page 1 of 10
